PatientsVille.com LogoPatientsVille.com

Menopause | Alternative Treatments for Menopausal Women

Menopause research study

What is the primary objective of this study?

To investigate the reported health benefits (lipid profile, inflammatory factors, cardiovascular status and bone density) of a novel, phytoestrogen rich, Red Clover treatment on women suffering from both menopause related primary (hot flushes, night sweats, sleep disturbance and weight gain) and secondary (osteoporosis, cardiovascular and changes in lipid metabolism) symptoms.

Who is eligible to participate?

Inclusion Criteria: - Women aged 40-65 years - Experiencing daily hot flushes - Body Mass Index (BMI) between 20-40 - Irregular menstrual bleeding - FSH levels above the normal range Exclusion Criteria: - Simultaneous participation in other clinical trials within the last 3 months - Severe cardiovascular, psychiatric, neurological, and/or kidney disease. - Alcohol or drug abuse and acute illness. - Blood pressure > 160/110 - Pregnant and lactating women

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Menopause

Hot Flushes

Osteoporosis

Dyslipidemia

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Dietary Supplement:Placebowater with color

Dietary Supplement:Red Clover extractRed Clover extract containing 80 mg Isoflavones. Dosage: 2 X 75 ml/day

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Red Clover extract150 ml/d Red Clover extract

Placebo150 ml/d sweetened and coloured water

Study Status

Completed

Start Date: June 2012

Completed Date: December 2014

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Primary Menopause-related symptoms

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Per B Jeppesen, Prof

Lead Sponsor: Aarhus University Hospital

Collaborator:

More information:https://clinicaltrials.gov/show/NCT02028702

Discuss Flushing